Q1 2026 · 13F-HR
KVP Capital Advisors, LPholdings as filed
Filed 2026-05-13 · accession 0001104659-26-060329
$133.9M
Reported value
32
Positions
2026-03-31
Period end
The Brief · KVP Capital Advisors, LP · Q1 2026
AI · grounded in 13F
KVP Capital Advisors, LP initiated a new position in STRO worth $5.64M, marking its largest move of the period. The fund also established new stakes in ERAS for $5.5M and TNGX for $4.82M. These additions coincided with the complete exit of positions in JAZZ and FULC.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $23.2M | 17.3% | 440,000 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $13.8M | 10.3% | 42,900 | Common | SOLE |
| 00032Q104 | WHWK | WHITEHAWK THERAPEUTICS INC | $7.5M | 5.58% | 2,165,997 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $6.1M | 4.57% | 36,200 | Common | SOLE |
| 869367201 | STRO | SUTRO BIOPHARMA INC | $5.6M | 4.22% | 226,575 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.6M | 4.17% | 53,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $5.5M | 4.11% | 340,000 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $4.9M | 3.69% | 414,000 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $4.8M | 3.60% | 230,264 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $4.7M | 3.48% | 28,497 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $4.2M | 3.13% | 133,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $3.9M | 2.92% | 40,200 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $3.7M | 2.78% | 58,250 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $3.6M | 2.71% | 121,524 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $3.3M | 2.47% | 605,280 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $2.8M | 2.10% | 4,750 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $2.7M | 2.02% | 91,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $2.7M | 1.98% | 79,700 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $2.6M | 1.98% | 500,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $2.5M | 1.90% | 300,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $2.4M | 1.83% | 125,000 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $2.3M | 1.73% | 31,813 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $2.2M | 1.66% | 373,128 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $2.2M | 1.65% | 45,000 | Common | SOLE |
| 45258H106 | IMMX | IMMIX BIOPHARMA INC | $2.1M | 1.57% | 230,423 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $2.0M | 1.49% | 59,700 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $1.9M | 1.45% | 26,900 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $1.4M | 1.02% | 505,431 | Common | SOLE |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $1.4M | 1.02% | 462,355 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $1.3M | 0.98% | 32,700 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $456,560 | 0.34% | 4,000 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $299,079 | 0.22% | 500,551 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.